APONVIE

NDC 47426-401 · Heron Therapeutics, Inc.

Generic nameAPREPITANT

Dosage formEMULSION

RouteINTRAVENOUS

Active ingredient(s)APREPITANT

Strength32 mg/4.4mL

Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Marketing categoryNDA

Packages

47426-401-10 — 10 VIAL, GLASS in 1 CARTON (47426-401-10) / 4.4 mL in 1 VIAL, GLASS (47426-401-01)

Billed under HCPCS

J8502 — Injection, aprepitant (aponvie), 1 mg Medicare Part B payment limit (ASP + 6%): $2.00

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-0461 — aprepitant, 0006-0462 — aprepitant, 0006-0464 — aprepitant, 0006-3066 — aprepitant, 0781-2321 — aprepitant, 0781-2322 — aprepitant, 0781-2323 — aprepitant, 13668-591 — APREPITANT, 13668-592 — APREPITANT, 13668-593 — APREPITANT, 47426-201 — aprepitant, 51407-701 — APREPITANT, 51407-702 — APREPITANT, 51407-703 — APREPITANT, 68001-666 — Aprepitant, 68001-667 — Aprepitant, 68001-668 — Aprepitant, 68462-583 — Aprepitant, 68462-584 — Aprepitant, 68462-585 — Aprepitant

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.